Articles tagged with Type 2 Diabetes
A study found African American children exhibited more risk factors for diabetes and cardiovascular disease than white children, despite healthier diets. The authors cautioned that the diets in this study were of poor quality according to national recommendations.
Researchers suggest that a significant majority of people with type 2 diabetes derive little additional benefit from annual eye screening. Instead, every other year or even every third year screening is nearly as beneficial and more cost-effective. This finding could lead to a shift in recommendations for optimal screening intervals.
A recent study found that poorly controlled type 2 diabetic patients are more likely to develop severe periodontal disease, with elevated serum triglycerides contributing to the issue. Reducing cholesterol and serum triglyceride levels through diet and exercise may help improve quality of life and oral health in diabetics.
A large-scale national study will investigate whether weight loss reduces cardiovascular disease and slows atherosclerosis progression in obese people with type 2 diabetes. The 7-year trial, funded by the National Institute of Diabetes and Digestive and Kidney Disorders, aims to enroll 6,000 participants.
A recent study found that nearly half of people with type 2 diabetes stop taking their oral anti-diabetic drugs (OADs), leading to a higher risk of complications such as blindness, amputation, and cardiovascular problems. The study revealed that individuals who discontinued treatment were almost three times more likely to die than thos...
A pan-European study found that type 2 diabetes in Europe is a significant healthcare burden, with total costs exceeding €29 billion and average individual costs more than double those of the general population. Preventing long-term complications through urgent action is crucial to reducing these costs.
Studies suggest that involving individuals with diabetes in their care can improve quality of life and reduce complications. The results highlight the importance of patient education and empowering patients to make informed treatment choices.
Researchers found that rosiglitazone treatment improved glycaemic control and reduced risk factors for coronary heart disease in patients with type 2 diabetes. The medication also showed promise in reducing protein excretion and triglycerides, while improving lipid profiles.
Rosiglitazone reduces insulin resistance by 33% and improves pancreatic function in individuals with type 2 diabetes. The treatment also reduces insulin levels in the blood, potentially alleviating the need for regular insulin injections.
Scientists have identified a genetic defect linked to insulin resistance and adult diabetes, providing a target for potential new treatments. The Q allele of the PC-1 gene is three times more common among insulin-resistant people and twice as frequent among adult diabetics.
Researchers found that resistant mice have higher levels of antioxidant enzymes, which help protect against pancreatic beta-cell destruction. The study suggests a single gene may be responsible for the genetic resistance, and identifying it could lead to therapies to boost natural defenses against diabetes.
Researchers found that stress and coping measures can affect blood sugar control in people with diabetes. The study's biopsychosocial model suggests that psychological factors interact with biological factors to regulate blood sugar levels.
A study of 12,330 men and women aged 45-64 found that those with high levels of white blood cells, albumin, or fibrinogen were at higher risk of developing diabetes. The research suggests that inflammation may play a central role in the development of Type 2 diabetes.
A study of 254 women with Polycystic Ovary Syndrome (PCOS) found that 7.5% had undiagnosed diabetes, compared to 1% in the general population. Insulin resistance is a key factor in PCOS-related glucose intolerance and diabetes risk.
Researchers at Duke University Medical Center found that a low-fat diet can reverse type 2 diabetes in mice by reducing insulin and glucose levels independently of weight loss. The study suggests that foods high in fat, not sugar, are responsible for the onset of diabetes.
The Rockefeller study aims to identify genetic causes of early- and late-onset type 2 diabetes to develop better diagnostic tools and improved drug therapies. The researchers seek individuals with type 2 diabetes and at least one affected family member to participate in the study.
A recent study has found that a mutation in the HNF4alpha gene causes MODY1, a rare form of Type 2 diabetes. The defect impairs glucose homeostasis and glycolysis pathways.
Researchers at Massachusetts General Hospital identified a new rare form of diabetes, MODY4, associated with the ipf-1 gene. The study found that most family members with diabetes carried a single copy of the mutation, highlighting the critical role of this gene in insulin secretion.
An international research group has located a new gene, NIDDM2, linked to type 2 diabetes in Finland. The gene is found in the same region as MODY3, a rare early-onset form of diabetes.